Welcome to our dedicated page for Gevo SEC filings (Ticker: GEVO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Gevo, Inc. (GEVO) SEC filings page brings together the company’s regulatory disclosures, including Form 8-K current reports, that describe material events affecting this renewable fuels, chemicals, and carbon management business. These filings provide detail on topics such as executive leadership changes, amendments to corporate bylaws, project financing, carbon credit sales agreements, and tax credit transfer arrangements tied to ethanol and renewable natural gas production.
Through its filings, Gevo outlines how it monetizes Section 45Z Clean Fuel Production Credits generated from ethanol volumes at its North Dakota facility, including tax credit transfer agreements with financial institutions and banks. Other 8-Ks describe bond financing agreements used to refinance revenue bonds for its dairy-based renewable natural gas project in Iowa, as well as carbon dioxide removal sales agreements with counterparties like Biorecro North America, LLC for credits associated with its carbon capture and sequestration facilities.
Investors can use annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) to review segment information related to ethanol, renewable natural gas, and carbon activities, along with risk factors and management’s discussion and analysis. Current reports on Form 8-K capture governance developments such as the appointment of a new president who is expected to become chief executive officer, the adoption of third amended and restated bylaws, and other corporate actions.
On Stock Titan, these filings are complemented by AI-powered summaries that highlight key points from lengthy documents, helping readers understand complex items like tax credit transfer structures, carbon dioxide removal contracts, and project financing terms. Real-time updates from EDGAR ensure that new GEVO filings, including Forms 10-K, 10-Q, and 4 (insider transaction reports), are accessible as they are posted. This combination of primary documents and AI explanations can save time for users who want to track how Gevo structures its low-carbon fuel, RNG, and carbon credit businesses through formal SEC disclosures.
Form 144 filed for Gevo, Inc. (GEVO) discloses a proposed sale of 57,651 shares of common stock through Stifel Nicolaus on approximately 08/20/2025 with an aggregate market value of $93,942. The filing shows the shares originated from restricted stock units granted on various dates (08/29/2022, 08/03/2023, 05/22/2024) and that prior sales by the same person occurred on 06/03/2025 (10,810 shares) and 08/05/2025 (5,738 shares) generating gross proceeds of $12,572 and $7,061 respectively. The total shares outstanding reported in the form are 239,562,995, placing this proposed sale as a small fraction of the company’s outstanding common stock. The filer certifies no undisclosed material adverse information and provides broker details for the planned transaction.
Gary W. Mize, a director of Gevo, Inc. (GEVO), executed equity transactions on 08/18/2025. He exercised stock options to acquire 224,639 shares at an exercise price of $0.67 per share, increasing his direct holdings to 479,785 shares before a subsequent sale. On the same date he sold 91,459 shares in multiple transactions at a weighted-average price of $1.6757 per share (individual sale prices ranged from $1.67 to $1.76). After the sale his direct beneficial ownership was reported as 388,326 shares. The Form 4 was signed by an attorney-in-fact on 08/19/2025. The filing discloses the option exercise date, exercise price, number of shares acquired, number sold, and the weighted-average sale price range.
Gevo, Inc. filed a Form 144 notifying the planned sale of 91,459 shares of common stock through Stifel Nicolaus & Company, Inc. on 08/18/2025 on Nasdaq. The filing shows the shares carry an aggregate market value of $153,258 and that the issuer has 241,839,083 shares outstanding. The securities were acquired by the seller on 05/23/2025 via an option exercise from the issuer, totaling 224,639 shares acquired; payment is indicated as cash with an indicated payment date of 08/18/2025. The filer reports no sales of the issuer's securities in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Amorelli Angelo, a director of Gevo, Inc. (GEVO), reported stock option exercise and subsequent open-market sales. On 08/12/2025 the reporting person acquired 100,000 shares by exercising options at an exercise price of $0.67 per share. That same day the filing shows sales of 183,515 shares reported under a 10b5-1 plan at a weighted average price of $1.9484 per share, and on 08/13/2025 an additional 16,485 shares were sold at a weighted average price of $2.00 per share. After these transactions the reporting person beneficially owned 124,639 derivative-backed shares and 2,942 to 202,942 common shares depending on the line item reported in the filing.
Gevo, Inc. filed an amendment to its annual report for the year ended December 31, 2024 to update the section on other information. The change adds details about Rule 10b5-1 trading arrangements adopted, modified, or terminated by its directors and executive officers during the three months ended December 31, 2024, after these arrangements were inadvertently omitted from the original filing.
The amendment lists plans for the CEO, CFO and other senior officers, as well as directors Angelo Amorelli and Gary W. Mize, including adoption and termination dates, plan durations, and the maximum number of shares that may be bought or sold under each plan. No financial statements are changed, and the company states that all other disclosures in the original annual report remain unchanged. As of January 31, 2025, Gevo had 240,499,833 shares of common stock outstanding.
Gevo, Inc. has filed a Form 144 proposing the sale of 200,000 shares of common stock through Stifel Nicolaus, with an aggregate market value of $389,680 and an approximate sale date of 08/12/2025 on Nasdaq. The filing reports 241,839,083 shares outstanding, which provides context for the proposed sale size relative to the company's share base.
The securities to be sold were acquired as equity compensation: 100,000 shares from an options exercise dated 05/23/2024 and 100,000 shares from restricted stock awards dated 10/15/2023 (with a noted payment date of 10/15/2024). The filer also represents they are not aware of undisclosed material adverse information about the issuer.
Gevo, Inc. (GEVO) reported a sharp operating turnaround in Q2 2025 as revenue rose to $43.4 million from $5.3 million a year earlier, producing a GAAP net income of $2.7 million for the quarter versus a loss in the prior-year period. For the six months the company recorded $72.5 million of revenue and a consolidated net loss of $19.0 million, driven by acquisition-related costs, depreciation and tax-credit accounting.
The company completed the Red Trail Energy acquisition (purchase price ~$210.3 million), adding an ethanol facility, carbon capture and sequestration assets, customer-related intangibles (~$46.3 million) and goodwill (~$39.8 million). Gevo recognized $21.5 million of Section 45Z clean fuel production tax credits as intangible assets and as a reduction to cost of goods sold and entered into a transfer agreement to monetize those credits. Cash and equivalents fell to $57.3 million at June 30, 2025, with restricted cash of $69.6 million; financing included a ~$105 million senior secured term loan and $5 million equity from a partner.
Gevo, Inc. notified investors that it has issued a press release reporting its financial results for the quarter ended June 30, 2025. The press release is furnished as an exhibit to this Current Report and the filing notes that the exhibit is provided for informational purposes rather than incorporated as a filed document.
The 8-K does not include numerical financial statements or operating metrics; it references an earnings press release (Exhibit 99.1) and an interactive cover page data file (Inline XBRL). Readers must consult the referenced press release exhibit for the detailed results and any financial metrics.
FAQ
What is the current stock price of Gevo (GEVO)?
What is the market cap of Gevo (GEVO)?
